Potentiation of a p53-SLP vaccine by cyclophosphamide in ovarian cancer: A single-arm phase II study

International Journal of Cancer ◽

10.1002/ijc.27388 ◽

2012 ◽

Vol 131 (5) ◽

pp. E670-E680 ◽

Author(s):

Renee Vermeij ◽

Ninke Leffers ◽

Baukje-Nynke Hoogeboom ◽

Ineke L.E. Hamming ◽

Rinze Wolf ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Download Full-text

Faculty of 1000 evaluation for Phase II study of interval debulking surgery followed by intraperitoneal chemotherapy for advanced ovarian cancer: A Kansai Clinical Oncology Group study (KCOG9812).

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.717962364.793467463 ◽

2012 ◽

Author(s):

Steve Plaxe ◽

Kristy Ward

Keyword(s):

Ovarian Cancer ◽

Clinical Oncology ◽

Phase Ii ◽

Intraperitoneal Chemotherapy ◽

Phase Ii Study ◽

Advanced Ovarian Cancer ◽

Oncology Group ◽

Debulking Surgery ◽

Oncology Group Study ◽

Interval Debulking Surgery

Download Full-text

Faculty of 1000 evaluation for A two-stage, single-arm, phase II study of EGCG-enriched green tea drink as a maintenance therapy in women with advanced stage ovarian cancer.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718090132.793484871 ◽

2013 ◽

Author(s):

Roberto Angioli

Keyword(s):

Ovarian Cancer ◽

Maintenance Therapy ◽

Green Tea ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Stage ◽

Download Full-text

A phase II study of fulvestrant in the treatment of multiply-recurrent epithelial ovarian cancer

Gynecologic Oncology ◽

10.1016/j.ygyno.2009.01.012 ◽

2009 ◽

Vol 113 (2) ◽

pp. 205-209 ◽

Author(s):

Peter A. Argenta ◽

Sajeena G. Thomas ◽

Patricia L. Judson ◽

Levi S. Downs ◽

Melissa A. Geller ◽

...

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Phase Ii ◽

Download Full-text

Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer

The Women s Oncology Review ◽

10.3109/14733400410001669533 ◽

2004 ◽

Vol 4 (1) ◽

pp. 45-46

Author(s):

Agustin Garcia

Keyword(s):

Ovarian Cancer ◽

Luteinizing Hormone ◽

Phase Ii ◽

Phase Ii Study ◽

Luteinizing Hormone Releasing Hormone ◽

Releasing Hormone ◽

Platinum Resistant

Download Full-text

Gemcitabine combined with cisplatin as first-line treatment in patients 60 years or older with epithelial ovarian cancer: a phase II study

International Journal of Gynecological Cancer ◽

10.1046/j.1525-1438.2003.13039.x ◽

2003 ◽

Vol 13 (2) ◽

pp. 130-137 ◽

Author(s):

T. Bauknecht ◽

A. Hefti ◽

G. Morack ◽

C. Villena-Heinsen ◽

D. Wallwiener ◽

...

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line Treatment

Download Full-text

A phase II study of erlotinib (OSI-774) given in combination with carboplatin in patients with recurrent epithelial ovarian cancer (NCIC CTG IND.149)

Gynecologic Oncology ◽

10.1016/j.ygyno.2010.05.005 ◽

2010 ◽

Vol 118 (3) ◽

pp. 308-312 ◽

Author(s):

H. Hirte ◽

A. Oza ◽

K. Swenerton ◽

S.L. Ellard ◽

R. Grimshaw ◽

...

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Phase Ii ◽

Download Full-text

A phase II study of docetaxel weekly in combination with carboplatin every three weeks as first line chemotherapy in stage IIB-IV epithelial ovarian cancer: Neurological toxicity and quality-of-life evaluation

International Journal of Oncology ◽

10.3892/ijo.2011.1286 ◽

2011 ◽

Author(s):

Bengt Sorbe

Keyword(s):

Quality Of Life ◽

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Neurological Toxicity ◽

Life Evaluation ◽

Line Chemotherapy

Download Full-text

Paclitaxel-cisplatin combination in advanced ovarian cancer: a phase II study

International Journal of Clinical Oncology ◽

10.1007/s101470050096 ◽

2000 ◽

Vol 5 (2) ◽

pp. 85-88

Author(s):

T. Sugiyama ◽

M. Yakushiji ◽

Y. Aoki ◽

K. Tanaka ◽

R. Nishimura ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Ovarian Cancer

Download Full-text

A phase II study of durvalumab, a PD-L1 inhibitor and olaparib in recurrent ovarian cancer (OvCa)

Annals of Oncology ◽

10.1093/annonc/mdy285.145 ◽

2018 ◽

Vol 29 ◽

pp. viii334 ◽

Author(s):

J.-M. Lee ◽

C.M. Annunziata ◽

N. Houston ◽

E.C. Kohn ◽

S. Lipkowitz ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Recurrent Ovarian Cancer

Download Full-text

First line dosointensive chemotherapy for Disseminated ovarian cancer after non optimal Cyted reduction: Results of the phase ii study

Practical oncology ◽

10.31917/2101037 ◽

2020 ◽

Vol 21 (1) ◽

pp. 37-45

Author(s):

A.A. Rumyantsev ◽

A.S. Tyulyandina ◽

I.A. Pokataev ◽

K.Yu. Morkhov ◽

V.M. Nechushkina ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Download Full-text